W

WATSON FUND, L.P.

0 employees

Healthcare venture capital fund that specializes in early-stage investments in a broad range of life science opportunities.

Investor insights

Sectors invested in

Biotechnology4
Pharmaceutical3
Therapeutics3
Health Care3
small molecule therapeutics1
neuroprotective1
neurodegenerative1
Neuroscience1
Wellness1
Oncology1
Pharmaceuticals1

Funding rounds participated in

$19M sweet spot round size

Most of their 4 investments are in rounds between $5.9M and $31M

Investor type

Venture Capital

Basic info

Date founded

2015

Investments made

M

Magnolia Neurosciences raised $31M on August 13, 2018

Investors: Lilly Asia Ventures, MD Anderson Cancer Center, ARCH Venture Partners, WuXi AppTec and WATSON FUND, L.P.

R

Rodeo Therapeutics raised $5.9M on July 25, 2017

Investors: Washington Research Foundation, ARCH Venture Partners, WuXi AppTec and WATSON FUND, L.P.

A

ApoGen Biotechnologies, Inc. raised $7M on December 12, 2016

Investors: Washington Research Foundation, WuXi AppTec, ARCH Venture Partners and WATSON FUND, L.P.

P

Petra Pharma Corporation raised $48M on January 6, 2016

Investors: ARCH Venture Partners, Partnership for New York City and WATSON FUND, L.P.

FAQ